High Mobility Group 20B (HMG20B) (Middle Region) Peptide
HMG20B
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN978045
Aperçu rapide pour High Mobility Group 20B (HMG20B) (Middle Region) Peptide (ABIN978045)
Antigène
HMG20B
(High Mobility Group 20B (HMG20B))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-HMG20B antibody (Catalog #: ARP35798_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- HMG20B (High Mobility Group 20B (HMG20B))
-
Sujet
-
HMG20B is required for correct progression through G2 phase of the cell cycle and entry into mitosis. HMG20B is also required for RCOR1/CoREST mediated repression of neuronal specific gene promoters.
Alias Symbols: BRAF25, BRAF35, FLJ26127, HMGX2, PP7706, SMARCE1r, SOXL, pp8857, HMGXB2
Protein Interaction Partner: BRCA2,CCDC85B,HNRNPL,KIF4A,PHF21A,TACC2,VIM,BRCA2,CCDC85B,HDAC1,HDAC2,HNRNPL,KDM1A,KIF4A,PHF21A,RCOR1,SF3A2,TACC2,VIM
Protein Size: 317 -
Poids moléculaire
- 37 kDa
-
ID gène
- 10362
-
NCBI Accession
- NM_006339, NP_006330
-
UniProt
- Q9P0W2
Antigène
-
Vous êtes ici:
